Several limitations should be considered
Mechanism and duration of action : Prescription semaglutide provides continuous GLP-1 receptor activation throughout the week due to its extended half-life and high receptor binding affinity
Retatrutide, with its triple action on GLP-1, GIP, and glucagon receptors, is the most advanced example yet
Total weight loss of 15 to 25 percent of starting weight is typical with consistent treatment
After reconstitution, store at 28C and use within the recommended period
A different non-insulin injectable diabetes medication Victoza (liraglutide) was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. And this first warning isnt an anomaly